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Classical UDP-glucose 6-dehydrogenases (UGDHs; EC
1.1.1.22) catalyze the conversion of UDP-␣-D-glucose (UDPGlc) to the key metabolic precursor UDP-␣-D-glucuronic acid
(UDP-GlcA) and display specificity for UDP-Glc. The fundamental biochemical and structural study of the UGDH homolog
CalS8 encoded by the calicheamicin biosynthetic gene is
reported and represents one of the first studies of a UGDH homolog involved in secondary metabolism. The corresponding
biochemical characterization of CalS8 reveals CalS8 as one of
the first characterized base-permissive UGDH homologs with a
>15-fold preference for TDP-Glc over UDP-Glc. The corresponding structure elucidations of apo-CalS8 and the CalS8䡠
substrate䡠cofactor ternary complex (at 2.47 and 1.95 Å resolution,
respectively) highlight a notably high degree of conservation
between CalS8 and classical UGDHs where structural divergence
within the intersubunit loop structure likely contributes to the
CalS8 base permissivity. As such, this study begins to provide a
putative blueprint for base specificity among sugar nucleotide-dependent dehydrogenases and, in conjunction with prior studies on
the base specificity of the calicheamicin aminopentosyltransferase
CalG4, provides growing support for the calicheamicin aminopentose pathway as a TDP-sugar-dependent process.
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UDP-glucose 6-dehydrogenases (UGDHs;3 EC 1.1.1.22) catalyze the conversion of UDP-␣-D-glucose (UDP-Glc) to the key
metabolic precursor UDP-␣-D-glucuronic acid (UDP-GlcA) (1,
2). In higher eukaryotes and humans, UDP-GlcA serves as a
biosynthetic precursor to important proteoglycans and glycosaminoglycans and is a substrate for UDP-glucuronosyltransferase-catalyzed glucuronidation, a reaction estimated to
account for ⬃35% of all drugs metabolized by phase II drugmetabolizing enzymes (3). In bacteria and fungi, UDP-GlcA is a
key substrate in primary metabolism for the production of glycoconjugates that contribute to pathogenicity, virulence, and
antibiotic resistance (4 –7). Nucleotide diphosphate (NDP)GlcA has also recently been implicated as a key precursor to
novel functionalized pentoses appended to bioactive bacterial
secondary metabolites including enediynes (calicheamicin,
esperamicin, and maduropeptin) (8 –10), indolocarbazoles
(AT2433) (11), and orthosomycins (avilamycin and everninomicin) (12–14) (Fig. 1A). Biochemical and structural studies
of representative bacterial UDGHs involved in primary metabolism revealed these enzymes to exert a specificity for UDP-Glc,
to exist as dimers and, in some cases, to be regulated by bacterial
tyrosine kinases (2, 15–22). In contrast, the only UGDH from
secondary metabolism biochemically characterized thus far
(CalS8) revealed turnover with both UDP-Glc and TDP-␣-Dglucose (TDP-Glc) (9). To further probe the potential unique
nucleotide specificity of CalS8, herein we report the CalS8
kinetic parameters and x-ray structure determination. This
work highlights CalS8 to display the key structural/catalytic
signatures of UGDH family members with a modified intersub3

The abbreviations used are: UGDH, UDP-glucose 6-dehydrogenase; UDPGlc, UDP-␣-D-glucose; UDP-GlcA, UDP-␣-D-glucuronic acid; TDP-Glc, TDP␣-D-glucose; TGDH, TDP-␣-D-glucose dehydrogenase; NDP, nucleotide
diphosphate; Ni-NTA, nickel-nitrilotriacetic acid.
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Background: The biosynthesis of deoxypentoses appended to bacterial secondary metabolites is poorly understood.
Results: Characterization of CalS8, a putative sugar dehydrogenase in calicheamicin biosynthesis, reveals unique base permissivity with a bias toward TDP-glucose.
Conclusion: CalS8 contains a modified intersubunit loop implicated as the substrate specificity factor in this prototype
dehydrogenase.
Significance: This work presents a new blueprint for base specificity annotation among putative UGDHs.

Structure of the TDP-␣-D-Glucose Dehydrogenase CalS8

unit loop structure caused by the insertion of three amino acid
residues (Gly259-Ser260-Ser261) and deletion of a conserved
UGDH Phe/Tyr residue as potential contributors to the determined ⬎20-fold lower Km for TDP-Glc. As the first biochemical and structural characterization of a base-permissive UGDH
family member with preference for thymidine, this study presents a basis for annotation of CalS8 as a TDP-␣-D-glucose dehydrogenase (TGDH) and a potential structural blueprint for
divergent base specificity among putative UGDHs in bacterial
secondary metabolism.

Experimental Procedures
Materials—Escherichia coli B834 (DE3) and BL21 (DE3)Gold strain competent cells were purchased from Stratagene
(La Jolla, CA). The pET-28b E. coli expression vector and
thrombin were purchased from Novagen (Madison, WI). Primers were purchased from Integrated DNA Technologies (Coralville, IA). Pfu DNA polymerase was purchased from Stratagene (La Jolla, CA). Restriction enzymes and T4 DNA ligase
were purchased from New England Biolabs (Ipswich, MA). NiNTA superflow column and gel filtration column HiLoad
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16/600 were purchased from GE Healthcare. Amicon Ultra威
centrifugal filters were purchased from EMD Millipore (Merck
KGaA, Darmstadt, Germany), and L-selenomethionine was
purchased from Medicilon, Inc. (Shanghai, China). Crystal
screen kits were purchased from Hampton Research (Aliso
Viejo, CA), Molecular Dimensions (Altamonte Springs, FL),
Rigaku (Seattle, WA), and Microlytic (Burlington, MA). All
other chemicals were reagent grade or better and purchased
from Sigma. X-ray data were collected at beamline 21-ID-F (LSCAT) of the Advanced Photon Source at Argonne National
Laboratory (Chicago, IL) and at the 19-ID and 19-BM beamlines of the Structural Biology Center at the Advanced Photon
Source (Chicago, IL). Analytical reverse-phase HPLC (Varian
Pro-Star equipped with photodiode array detector, Model 330,
Santa Clara, CA) was conducted using a Gemini NX C-18 (5
m, 250 ⫻ 4.6 mm) column (from Phenomenex, Torrance,
CA).
Gene Cloning and Expression and Protein Purification—For
biochemical studies, the wild-type calS8 gene (National Center
for Biotechnology Information (NCBI) accession, gi: 21637116;
accession: AAM70332.1) from the genomic DNA of caliVOLUME 290 • NUMBER 43 • OCTOBER 23, 2015
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FIGURE 1. Aminopentose-containing metabolites and corresponding biosynthetic pathways. A, pentose-containing bacterial secondary metabolites
where corresponding pentoses are highlighted in blue. B, proposed biosynthetic pathway of aminodideoxypentose shared by calicheamicin, esperamicin, and
AT2433 where steps for which biochemical characterization exists are denoted with solid arrows and putative steps (based upon sequence-guided annotation)
are illustrated with dotted arrows. The CalS8-catalyzed reaction is highlighted within the box.

Structure of the TDP-␣-D-Glucose Dehydrogenase CalS8
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was purified via Ni-NTA affinity chromatography using the
ÄKTAxpress system (GE Health Systems) following a protocol
with linear imidazole (10 –250 mM) elution gradient. This was
followed by the cleavage of the His6 tag using recombinant
His6-tagged tobacco etch virus protease at 4 °C for 24 – 48 h,
with an additional Ni-NTA purification to remove the protease,
uncut protein, and affinity tag. The pure protein was concentrated using Amicon Ultra威-15 concentrators (Millipore, Bedford, MA) in 20 mM HEPES, pH 8.0, buffer, 250 mM NaCl, and 2
mM DTT. Protein concentrations were determined from the
absorbance at 280 nm using a molar absorption coefficient
(⑀280 ⫽ 33,960 M⫺1 cm⫺1) calculated by using the method
developed by Gill and von Hippel (27). The concentration of
protein sample used for crystallization was 42.3 mg ml⫺1. A
second batch was purified for co-crystallization with various
ligands. This batch was grown the same except that inhibitory
amino acids and selenomethionine were not added. The concentration of native protein samples used for crystallization was
43.0 mg ml⫺1. Individual aliquots of purified protein were
stored at ⫺80 °C until needed.
Protein Crystallization—Enzyme from the above-mentioned
production for crystallography was screened against crystallization conditions with the help of the Mosquito liquid dispenser (TTP Labtech, Cambridge, MA) using the sitting-drop
vapor-diffusion technique in 96-well CrystalQuick plates
(Greiner Bio-One, Monroe, NC). For each condition, 0.4 l of
protein and 0.4 l of crystallization formulation were mixed;
the mixture was equilibrated against 140 l of the reservoir in
the well. Protein from the second batch was used to prepare
protein-ligand complexes by mixing protein with the following
combinations at 4 °C for several hours before setting up crystallizations: 4.51 mM UDP-Glc and 4.51 mM NAD⫹; 4.51 mM
UDP-Glc and 4.51 mM NADH; 4.51 mM TDP-Glc and 4.51 mM
NAD⫹; or 4.51 mM UDP-GlcA acid and 4.51 mM NAD⫹. Several commercially available crystallization screens were used
including: MCSG-1-3 (Microlytic Inc.) at 24 and 4 °C for the
apo-protein and MCSG-1-4 at 24 °C for the protein-ligand
complexes. Crystals were obtained under several conditions.
The best crystals for the apo-form appeared at 24 °C under the
condition 15% PEG 3350 and 0.1 M magnesium formate, which
corresponds to condition G10 from the MCSG-1 screen. The
crystals grew within 2 weeks. The best crystals for the proteinligand complexes appeared with 4.51 mM TDP-Glc and 4.51
mM NAD⫹ at 24 °C under the condition 16% PEG 4000, 0.1 M
Tris, pH 8.5, and 0.2 M magnesium chloride, which corresponds
to condition F4 from the MCSG-4 screen. The crystals grew
within 2 weeks. The apo and substrate-bound forms of P294S
crystals were cryoprotected by a brief transfer to the crystallization solution plus 20% glycerol and flash-frozen in liquid
nitrogen.
Data Collection and Structure Refinement—X-ray diffraction
data of Se-Met (apo) and native (complexed with TDP-Glc and
NAD⫹) enzymes were collected at the 19-BM and 19-ID beamlines of the Structural Biology Center at the Advanced Photon
Source at the Argonne National Laboratory. The data for apoenzyme were collected at beamline 19-BM, whereas for substrate-bound enzyme, 19-ID was used. In both cases, the datasets were collected at 100 K at the wavelength corresponding to
JOURNAL OF BIOLOGICAL CHEMISTRY
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cheamicin producer, Micromonospora echinospora LL6600,
was amplified by PCR using designed primers containing suitable NdeI (forward) and EcoRI (reverse) restriction sites (5⬘AATTCCATATGTTCCTTCCCGACCC-3⬘ forward and 5⬘AATTCGAATTCTCACCTTCCAATGCCGCGGTAGG-3⬘
reverse primers). The PCR products were digested and ligated
into pET28a to provide a production construct, confirmed via
sequencing, for the N-terminal-His6-CalS8 fusion protein
(referred to simply as CalS8 in the current study). Production of
CalS8 in E. coli BL21(DE3) was accomplished by inoculation of
LB containing 35 g ml⫺1 of kanamycin and subsequent
growth at 37 °C at 200 rpm to an A600 of ⬃0.6, at which time the
temperature was lowered to 25 °C and expression was induced
with 0.5 mM isopropyl-␤-D-thiogalactoside. Cells were allowed
to continue to grow at 25 °C for ⬃18 h at 220 rpm. The cells
were harvested by centrifugation (6,000 ⫻ g at 4 °C for 20 min),
resuspended in buffer A (20 mM NaH2PO4, 300 mM NaCl, 10
mM imidazole, pH 7.8), and purified as described above via NiNTA affinity chromatography using an ÄKTA Purifier 10 (GE
Healthcare). Buffer exchange of pooled fractions containing the
purified CalS8 was accomplished using a PD-10 column (GE
Healthcare) eluted with 25 mM Tris buffer, pH 8, to provide
recovered protein at a final concentration of 20 mg ml⫺1. Final
purified CalS8 was drop-frozen in liquid nitrogen and stored at
⫺80 °C. Protein purity was confirmed by SDS-PAGE, and protein concentration was determined using the Bradford protein
assay kit (from Bio-Rad) using BSA as a standard.
For structural studies, calS8 gene was amplified by PCR from
M. echinospora genomic DNA with KOD Hot Start DNA polymerase using the 5⬘-TACTTCCAATCCAATGCCATGCCGTTCCTTCCCGACCC-3⬘ forward and 5⬘-TTATCCACTTCCAATGTTACCTTCCAATGCCGCGGTAGG-3⬘ reverse
primers. The amplification buffer was supplemented with betaine to a final 2.5 M concentration. PCR products were purified,
treated with T4 polymerase (23), and cloned into the pMCSG68
vector according to ligation-independent procedures (24, 25),
and the corresponding final clone was determined via sequencing as a CalS8 P294S mutant. This N-terminal tobacco etch
virus protease-cleavable StrepII/His6-CalS8 dual-tagged production vector was transformed into E. coli BL21(DE3)-Gold
strain. The clone was subsequently validated in small scale production, Ni-NTA affinity purification, and tobacco etch virus
protease cleavage propensity of the affinity tag. For large-scale
protein production, bacterial culture was grown at 37 °C and
190 rpm in 1 liter of enriched M9 medium (26). When the A600
reached ⬃1, the culture was air-cooled to 4 °C over a 60-min
period and supplied with 90 mg liter⫺1 of L-selenomethionine
(Se-Met) and 25 mg liter⫺1 of each of the methionine biosynthetic inhibitory amino acids (L-valine, L-isoleucine, L-leucine,
L-lysine, L-threonine, L-phenylalanine). Gene expression was
induced by the addition of isopropyl-␤-D-thiogalactoside to a
final concentration of 0.5 mM, and the cultures were subsequently grown overnight at 18 °C. The cells were harvested and
resuspended in lysis buffer (500 mM NaCl, 5% (v/v) glycerol, 50
mM HEPES, pH 8.0, 20 mM imidazole, and 10 mM ␤-mercaptoethanol). Cells were disrupted by lysozyme treatment (1 mg
ml⫺1) and sonication, and the insoluble cellular material was
removed by centrifugation. The corresponding N-His6-CalS8

Structure of the TDP-␣-D-Glucose Dehydrogenase CalS8
TABLE 1
Summary of CalS8 (P294S) crystal parameters, data collection, and refinement statistics
Values in parentheses are for the highest resolution shell.
apo-CalS8

CalS8䡠TMP䡠NADⴙ complex

P21
70.39, 88.20, 70.94 103.4

P21
70.68, 87.04, 70.66 103.4

Data collection statistics
Wavelength (Å)
Resolution range (Å)
Unique reflections
Completeness (%)
Rmergea
Multiplicity
Mean I/(I)
CC1/2(CC*)

0.9793
40.0–2.55
27,596 (1,381)
99.9 (100)
0.16 (0.93)
3.8 (3.8)
10.6 (1.74)
0.619 (0.875)

0.9792
30.0–1.95
60,172 (2,978)
99.9 (100)
0.07 (0.72)
3.9 (3.9)
22.10 (2.22)
0.746 (0.924)

Refinement and model statistics
Rcrystb/Rfreec
Resolution (Å)
Reflections work/test set
RMSD bond lengths (Å)
RMSD bond angles (°)
B factor - protein/GOL/TMP/NAD/Na/solvent (Å2)
No. of protein atoms
No. of waters
No. of auxiliary molecules in the asymmetric unit

0.184/0.225
37.16–2.55
26,452/1,128
0.010
0.810
49.7/52.3/-/-/-/34.3
6,640
85
1 GOL

0.171/0.205
28.19–1.95
57,108/3,044
0.009
0.74
40.7/52.2/42.7/61.9/47.7/41.0
6,726
293
1 GOL, 1 TMP, 1 NAD, 1 Na⫹

Ramachandran plot (%)
Favorable region
Outliers
Clashscored

97.9
0
2.25

97.9
0
1.40

PDB

4XRR

4XR9

Rmerge ⫽ 兺h 兺i 兩 Ii(h) ⫺ 具I(h)典兩/兺h兺i Ii(h), where Ii(h) is the intensity of an individual measurement of the reflection and 具I(h)典 is the mean intensity of the reflection.
b
Rcryst ⫽ 兺h 储Fobs兩 ⫺ 兩Fcalc储/兺h 兩Fobs兩, where Fobs and Fcalc are the observed and calculated structure-factor amplitudes, respectively.
c
Rfree was calculated as Rcryst using 5.0% of randomly selected unique reflections that were omitted from the structure refinement.
d
As defined by MolProbity.
a

the selenium K-absorption edge. All data were processed and
scaled using HKL3000 (28). Intensities were converted to structure factor amplitudes in the Ctruncate program (29, 30) from
the CCP4 package (31). As the selenium anomalous signal was
too weak for experimental phasing, the structure of the apoenzyme form was solved by molecular replacement with
UGDH from Porphyromonas gingivalis as the template (Protein
Data Bank (PDB): 3GG2) using MR_Rosetta (32, 33). The initial
models were further built in COOT (34) and refined in
BUSTER (35) with NCS and translation/libration/screw (TLS)
restraints (6 TLS groups per protein chain). The structure of
substrate-bound enzyme was solved by molecular replacement
with the apo-form of P294S as a search model. The structure
was manually rebuilt and refined in BUSTER with TLS parameters (10 groups for chain A and 4 groups for chain B). The final
models have been validated with the MolProbity server (36).
The refinement statistics are shown in Table 1. The atomic
coordinates and structure factors have been deposited in the
Protein Data Bank under accession codes 4XRR (apo) and 4XR9
(substrate/NAD⫹-bound). Analysis and validation of structures were performed with the aid of MolProbity (36) and
COOT (34) validation tools. Figures were prepared using
PyMOL (62). Analysis of the corresponding structures revealed
the presence of a P294S mutation introduced as a PCR artifact
during initial cloning.
Enzymatic Activity and Kinetic Characterization—CalS8
activity assays were performed in a total volume of 100 l in 50
mM Tris-HCl buffer, pH 8, containing 2 mM (T/U)DP-Glc, 5
mM MgCl2, and 20 mM NAD⫹ and 4 M CalS8 or P294S at
30 °C. The progress of the reaction was monitored by the
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change in absorbance at 340 nm (⑀ ⫽ 6,220 M⫺1) on a BMG
Labtech FLUOstar Omega plate reader (Cary, NC), which
accompanies the reduction of NAD⫹ to NADH. Product formation was monitored via analytical reverse-phase HPLC (gradient of 1% B to 50% B over 30 min, 50% B for 5 min, 50% B to 1%
over 1 min, 1% B for 7 min (A ⫽ 50 mM phosphate buffer, pH 6,
with 5 mM tetrabutylammonium bisulfate; B ⫽ acetonitrile); 1
ml min⫺1; A254). Prior to HPLC analysis, the reaction mixture
was mixed with an equal volume of methanol and then centrifuged at 14,000 ⫻ g for 15 min to remove the precipitated protein. Subsequent confirmation of the product was achieved by
NMR. Kinetic parameters for TDP-Glc and UDP-Glc were measured under standard assay conditions by holding NAD⫹ constant (20 mM) and varying (T/U)DP-Glc (from 0.02 to 10 mM).
All reactions were performed in triplicate, and concentration of
product formed was calculated using NADH standard. The initial velocity data were fitted to the Michaelis-Menten equation
by nonlinear regression using GraphPad Prism4 software.

Results and Discussion
Overall Structure—Crystal structures of apo (P294S䡠Apo)
and ternary ligand-bound complex (P294S䡠TDP-Glc䡠NAD⫹)
CalS8 were determined at 2.47 and 1.95 Å resolution, respectively (PDB 4XRR and 4XR9, respectively). Both belong to the
P21 space group (Table 1) and contain two subunits in the
asymmetric unit with a large dimer subunit interaction surface
area of ⬃2,700 Å2 (Fig. 2). Although crystals of the ternary
P294S䡠TDP-Glc䡠NAD⫹ complex were obtained by co-crystallization in the presence of TDP-Glc and NAD⫹, electron density
for only the nucleotide monophosphate (TMP) portion of the
VOLUME 290 • NUMBER 43 • OCTOBER 23, 2015
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Crystal parameters
Space group
Unit-cell parameters a, b, c , ␤ (Å, °)

Structure of the TDP-␣-D-Glucose Dehydrogenase CalS8

FIGURE 3. CalS8 (PDB 4XR9) active site interactions. A, electron density map of NAD⫹ within CalS8 structure (PDB 4XR9; NAD⫹ occupancy is 0.9). B,
residues involved in cofactor binding where the putative regulatory tyrosine is highlighted in yellow and water molecules are represented as green
spheres. C, 2mFo-DFc electron density map contoured at 1 of TMP within CalS8 structure (PDB 4XR9; TMP occupancy is 0.9). D, residues involved in
binding the sugar-␣-1-phosphate portion of the substrate highlighting key residues involved in catalysis. Water molecules are represented as green
spheres, and lysine from the adjacent subunit is colored yellow.

OCTOBER 23, 2015 • VOLUME 290 • NUMBER 43
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FIGURE 2. Homodimer (left) and monomer (right) structure of CalS8 (PDB 4XR9). The N terminus NAD⫹-binding and C terminus substrate-binding domains
are colored brick-red and blue, respectively. The dimerization domain and intersubunit loops are colored gold and blue, respectively. The secondary structural
elements are labeled within the monomer structure.

Structure of the TDP-␣-D-Glucose Dehydrogenase CalS8
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a residue conserved among UGDHs that has been demonstrated to be modified via bacterial regulatory tyrosine kinases
(2, 15–22). Consistent with the observed preference for NAD⫹
(9), CalS8 also contains a conserved Asp42 (Fig. 3B), known to
be the determinant for specificity for NAD⫹ versus NADP⫹
(37).
To model sugar nucleotide binding, the ␣-1-sugar-phosphate of UDP-Glc from the crystal structure of hUGDH (PDB
2Q3E) (37) was appended to the determined CalS8-bound
TMP to afford a properly oriented sugar nucleotide ligandbound model. This docked model and the structure bound to
TMP suggest that the nucleotide base of TDP-Glc is surrounded by the intersubunit loop and anchored to the enzyme
through direct and indirect water-mediated hydrogen-bonding
interactions primarily originating from residues in the C-terminal domain, whereas N-terminal domain residues contribute to
corresponding substrate sugar and phosphate interactions. Key
interactions include: substrate thymidine O2 and O4 hydrogenbonding with the main-chain and side-chain amide NHs of
Leu267 and Arg430, respectively (Fig. 3D); thymidine endocyclic
N3 hydrogen-bonding with the main-chain carbonyl of Leu267;
hydrophobic interactions between the substrate thymidine C5
methyl and the hydrophobic surface created by the side chains
of Ile225, Val229, Leu266, and Val272; substrate nucleotide ribose
C3⬘-OH hydrogen-bonding with the main-chain amide and
carbonyl of Phe339, (Fig. 3D); and substrate nucleotide pyrophosphate hydrogen-bonding to the side-chain amine of Lys340
from the same subunit and Lys258 from the adjacent subunit
(Fig. 3D).
The active site cleft, formed by the interface of NAD⫹- and
TDP-Glc-binding domains, contains a number of residues conserved among NDP-glucose-dehydrogenase family members
(Cys276, Asp280, Lys218, Asn222, Thr132, Glu164, and Glu168; Fig.
3, B and D). Within this set, Cys276 is the catalytic residue that
forms covalent substrate-enzyme thiohemiacetal/ester intermediates in the oxidative half-reactions en route to NDP-GlcA
(2, 37, 42– 44). Within this context, Lys218 has been proposed to
act as general base and in oxyanion stabilization, whereas
Asp280 has been implicated in Cys276 deprotonation and oxyanion stabilization via coordination with an active site water
molecule. In addition, Glu164/Glu168 are proposed to function
as Brønsted bases in promoting the thioester hydrolysis,
whereas Asn222 and Thr132 are believed to also help to stabilize
the substrate C6⬙-oxygen negative charge over the course of the
reaction (2, 37, 42– 44). In the CalS8 docked model, the Cys276
side-chain thiol is 1.9 Å from the C6⬙-OH of the sugar (Fig. 3D),
consistent with the requisite covalent bond in catalysis. A water
molecule also implicated in catalysis (37, 44) is observed in the
CalS8 complex 3.2 Å from the substrate C6⬙-OH, which hydrogen-bonds to side-chain carboxylate of Asp280 and side-chain
hydroxyl of Thr132 (distance ⬃2.3 and 2.8 Å, respectively) (Fig.
3D). This core water molecule and the side-chain hydroxyl of
Thr132 also hydrogen-bond with the C2⬘-OH of ribose of
NAD⫹ (2.9 and 3.2 Å, respectively), facilitating the association
of the reactive groups of substrate and cofactor in the active site
(Fig. 3D).
Enzyme Activity and Base Specificity—Preliminary in vitro
end point assays for CalS8 revealed the enzyme to accept both
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sugar nucleotide (Fig. 3C) and NAD⫹ cofactor (Fig. 3A) was
observed in one of the two subunits (ligands have occupancy of
0.9). The absence of glucose 1-phosphate moiety could be a
result of disorder in the crystal or partial hydrolysis during crystallization. The remaining TMP moiety occupies essentially the
same position as that of UDP-Glc in other representative
ligand-bound UGDH structures such the hUGDH䡠UDP-GlcNADH complex (PDB 2Q3E) (where hUGDH is human
UGDH) (37). It is intriguing that the root mean square deviation (RMSD) between two monomers within the dimeric structures is ⬃2.5 Å, likely indicative of allosteric interaction
between two monomers. However, because the RMSD between
the apo and ternary complex structures is 0.37 Å, the remaining
discussion refers to the high-resolution structure of ternary
ligand-bound complex (P294S䡠TDP-Glc䡠NAD⫹) of CalS8.
The overall fold of CalS8 is similar to typical nucleotide sugar
dehydrogenases (2, 38 –39), bearing a bilobal structure consisting of a large N-terminal NAD⫹-binding domain and a small
C-terminal nucleotide sugar-binding domain, each adopting an
␣/␤ Rossmann fold (40) (Fig. 2, right panel). The dimer assembly is created through a head-to-tail arrangement of the individual subunits in a back-to-back orientation. Each subunit of
CalS8 contains one active site at the cleft formed by the interface of the two domains. The dimer interface is adjacent to the
active site, mainly formed by hydrophobic and hydrogen-bonding interactions involving a four-helical bundle (␣9 –␣12) connecting the N- and C-terminal domains (Fig. 2, right panel).
The N-terminal NAD⫹-binding domain has a mixed ␤-sheet
formed by eight ␤-strands (strand order ␤3, ␤2, ␤1, ␤4, ␤5, ␤6,
␤7, ␤8) where ␤7 and ␤8 are antiparallel. This large ␤-sheet is
flanked by ␣-helices ␣1–␣9 on both sides. The C-terminal
sugar nucleotide-binding domain is formed by a five-stranded
parallel ␤-sheet (strand order ␤13, ␤12, ␤11, ␤9, ␤10) flanked
by helices ␣12–␣18 on both sides. The N- and C-terminal
domains are connected by a linker domain consisting of a long
loop that extends to the adjacent subunit (referred to as the
intersubunit loop henceforth) (Fig. 2) flanked on both sides by
helices ␣10 (residues Asp245-Asn254) and ␣11 (residues Gly274Arg291) along with two long interdomain helices, ␣9 (residues
Ser210-Gly243) and ␣12 (residues Leu295-Leu323), respectively
(Fig. 2). When compared with UGDH structures, the most distinguishing feature of CalS8 is the modified intersubunit loop
containing the ␤-hairpin composed of two antiparallel
␤-strands (Ser251-Met252 and Pro257-Lys258) (Fig. 2) formed by
the insertion of three extra amino acid residues (Gly259-Ser260Ser261) when compared with other UGDHs.
Active Site—The NAD⫹ cofactor is situated on the top of the
␤-sheet of the N-terminal domain containing a classical glycine-rich Rossmann fold (residues Gly19-Ala20-Gly21-Tyr22Val23-Gly24) commonly implicated in NAD⫹ binding (Fig. 3B).
NAD⫹ also interacts with helix ␣11, a region containing the
characteristic GGXCXXKD sequence signature of nucleotide
sugar dehydrogenases (residues Gly273-Gly274-Ser275-Cys276Leu277-Thr278-Lys279-Asp280) known to participate in catalysis
(Fig. 3B and residues colored yellow in Fig. 4) (41). The endocyclic N1 from the adenine ring of NAD⫹ makes a hydrogenbonding interaction with the Tyr82 side-chain phenolic
hydroxyl of putative tyrosine residue (colored yellow in Fig. 3B),
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FIGURE 4. Comparison of CalS8 and representative known UGDH structures highlighting the residues implicated in base specificity. A, overlay highlighting the intersubunit loop of representative UGDH structures with CalS8䡠TMP䡠NAD⫹ ternary complex (colored white, PDB 4XR9). The overlaid UGDH
structures include human (PDB 2Q3E), P. gingivalis (PDB 3GG2), and B. cepacia (PDB 2Y0E). The intersubunit loop of UGDH and CalS8 are colored yellow and blue
respectively; black- and blue-colored labels correspond to residues of UGDH and CalS8 residues, respectively. The putative base specificity-modulating residues
of TGDH are colored red (red part of the loop corresponds to amino acid residues Gly259-Ser260-Ser261, and a red X corresponds to the position of deletion of a
residue in CalS8 (which in UGDHs is a Phe or Tyr)). B, sequence alignment of base binding sites of putative TGDHs (CalS8 from the calicheamicin producer
M. echinospora, PDB 4XR9; EspS8 from the esperamicin producer Actinomadura verrucosospora; AtmS8 from the AT2433 producer Actinomadura melliaura; and
MdpA2 from the maduropeptin producer Actinomadura madurae) and UGDHs with known structure (S. pyogenes (PDB 1DLI), K. pneumoniae (PDB 3PJG),
B. cepacia (PDB 2Y0E), P. gingivalis (PDB 3GG2), S. elodea (PDB 4A7P), P. islandicum (PDB 3VTF), and human (PDB 2Q3E)). The UGDHs are represented via PDB IDs
with conserved UGDH/TGDH signature motif (green box) and intersubunit (light yellow-shaded), and putative base specificity-modulating and catalytic residues
are highlighted (red and blue, respectively).
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TABLE 2
Determination of kinetic parameters for CalS8 and CalS8 mutant
P294S mutant using standard conditions with saturating (20 mM)
NADⴙ and varied (from 0.02 to 10 mM) UDP/TDP-Glc concentrations at
30 °C
Enzyme/Substrate

kcat
⫺1

CalS8/UDP-Glc
CalS8/TDP-Glc
P294S/TDP-Glc

min
1.6 ⫾ 0.1
1.3 ⫾ 0.1
1.0 ⫾ 0.1

Km

M
930.0 ⫾ 128.0
44.9 ⫾ 7.4
31.9 ⫾ 3.3

kcat/Km ⴛ 10ⴚ3
1.7
29.0
31.4
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UDP-Glc and TDP-Glc, and importantly, provided the first evidence in support of glucose rather than ribose as a progenitor of
functionalized pentoses in bacterial secondary metabolism (9).
When compared with most UGDHs that display specificity
toward UDP-Glc (18 –22, 44 – 48), a broader selectivity for the
nucleotide of CalS8 is uncommon and is consistent with the
demonstrated base specificity of the calicheamicin TDP-aminodideoxypentosyl transferase CalG4 (58 – 60). To further
probe the base specificity of CalS8, the kinetic parameters of
CalS8 with TDP-Glc and UDP-Glc as substrates were determined (Table 2). This analysis revealed the kcat of CalS8 in the
presence of UDP-Glc as only slightly better (1.2-fold) to that
with TDP-Glc. In contrast, a marked difference in Km was
observed with the Km of TDP-Glc (⬎20-fold improved over
that of UDP-Glc, translating to a ⬎15-fold enhancement of
specificity constant (kcat/Km) for TDP-Glc). Thus, although
CalS8 is capable of accepting both TDP-Glc and UDP-Glc, it is
formally considered a TGDH based upon this kinetic analysis.
Importantly, similar analysis of the corresponding P294S
mutant with TDP-Glc revealed the mutant to be a catalytically
competent model of the wild-type enzyme (Table 2).
To date, the PDB contains UGDH structures from eight different sources including: human (PDB 2Q3E, 2QG4, 3ITK,
3KHU, 3PRJ, 3PTZ, 3TDK, 3TF5, 4EDF, 4QEJ, 4RJT) (37, 42,
49 –51); thermophilic archaea, Pyrobaculum islandicum
(3VTF) (52); metazoan, Caenorhabditis elegans (PDB 2O3J);
and pathogenic bacteria such as Sphingomonas elodea (PDB
4A7P) (48), Burkholderia cepacia (PDB 2Y0C, 2Y0D, 2Y0E)
(53), Streptococcus pyogenes (1DLI, 1DLJ) (44), Klebsiella pneumoniae (3PHL, 3PID, 3PJG, 3PLN, 3PLR) (41), and P. gingivalis
(PDB 3GG2). All adopt the typical UGDH fold containing conserved residues necessary for cofactor binding and for catalysis
(Figs. 2 and 3). From structural and sequence alignments (Fig.
4), there are two distinguishing features in CalS8 that may contribute to base specificity. The first is the insertion of three
amino acid residues (Gly259-Ser260-Ser261, colored red within
the intersubunit loop in Fig. 4A, and red-colored residues in Fig.
4B) to form ␤-hairpin containing antiparallel ␤-strands (Ser251Met252 and Pro257-Lys258) in the intersubunit loop (Fig. 4A and
highlighted in yellow in Fig. 4B). The second is the deletion of
the conserved UGDH aromatic residue (F/Y, red cross in Fig. 4A
and highlighted in red in Fig. 4B) from the signature motif ((F/
Y)X5GG(F/Y)CXXKD, residues colored blue in Fig. 4B). Specifically, the insertion of three residues resulting in the reorientation of the intersubunit loop and deletion of the conserved
UGDH Phe/Tyr enables creation of extra space to accommodate the thymidine C5 methyl. In particular, the deletion of the
UGDH aromatic residue (which is Phe265, Tyr249, Tyr242,

Phe333, and Tyr253 of human, S. pyogenes, K. pneumoniae,
P. gingivalis, and P. islandicum UGDH, respectively) in CalS8 is
anticipated to relieve the potential for steric infringement upon
the thymidine C5 methyl. In addition, a conservative CalS8 Arg
to Lys258 substitution (Fig. 4 and yellow-colored residue in Fig.
3D) was observed in the context of the key side-chain residues
that contribute to substrate nucleotide pyrophosphate hydrogen-bonding from the adjacent subunit ␤-hairpin in the intersubunit loop (boxed in Fig. 1B). Although this conservative
side-chain substitution is less likely to impact upon base specificity, it is noteworthy that arginine is conserved at this position
among UGDHs. However, it is interesting to note the UGDH
arginine residue that hydrogen-bonds to C2⬘-OH of ribose is
also conserved in CalS8 (Arg430) and may explain the promiscuity of CalS8 toward UDP-Glc as a substrate. Importantly, of
the other putative TDGHs encoded by secondary metabolite
gene clusters (Fig. 4B, At2433 AtmS8, esperamicin EspS8, and
maduropeptin MdpA2), AtmS8 was also recently demonstrated to display a preference for TDP-Glc in vitro (63).
Conclusions—In summary, the reported determination of
fundamental kinetic parameters reveals CalS8 as one of the
first characterized examples of a base-permissive TGDH and
thereby extends understanding of progenitors to glycosylated
bacterial secondary metabolites bearing functionalized pentoses (55–57). The corresponding structure elucidation of the apo
and P294S䡠TDP-Glc䡠NAD⫹ ternary complexes highlights a
remarkably high degree of conservation between classical
UGDHs and this model TGDH where a modified intersubunit
loop structure caused by insertion of three residues and deletion of a UGDH conserved aromatic residue likely contributes
to the CalS8 base permissivity. As such, this study begins to
provide a putative blueprint for base specificity among sugar
nucleotide-dependent dehydrogenases. In addition, the demonstrated CalS8 preference for TDP-Glc is consistent with the
previously reported specificity of the culminating calicheamicin aminopentosyltransferase CalG4 for TDP in the context of
CalG4-catalyzed “reverse” reactions (58 – 60). Thus, the cumulative characterization of CalS8 and CalG4 provides growing
support for the calicheamicin aminopentose pathway as a TDPsugar-dependent process and contrasts the recently reported
characterization of CalS9 as a UDP-GlcA decarboxylase (61).

Structure of the TDP-␣-D-Glucose Dehydrogenase CalS8
References

OCTOBER 23, 2015 • VOLUME 290 • NUMBER 43

20. Jiang, S. S., Lin, T. Y., Wang, W. B., Liu, M. C., Hsueh, P. R., and Liaw, S. J.
(2010) Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in
polymyxin B resistance, swarming, and virulence. Antimicrob. Agents
Chemother. 54, 2000 –2009
21. Mainprize, I. L., Bean, J. D., Bouwman, C., Kimber, M. S., and Whitfield, C.
(2013) The UDP-glucose dehydrogenase of Escherichia coli K-12 displays
substrate inhibition by NAD that is relieved by nucleotide triphosphates.
J. Biol. Chem. 288, 23064 –23074
22. Grangeasse C, Obadia B, Mijakovic I, Deutscher J, Cozzone AJ, Doublet P.
(2003) Autophosphorylation of the Escherichia coli protein kinase Wzc
regulates tyrosine phosphorylation of Ugd, a UDP-glucose dehydrogenase. J. Biol. Chem. 278, 39323–39329
23. Kim, Y., Babnigg, G., Jedrzejczak, R., Eschenfeldt, W. H., Li, H., Maltseva,
N., Hatzos-Skintges, C., Gu, M., Makowska-Grzyska, M., Wu, R., An, H.,
Chhor, G., and Joachimiak, A. (2011) High-throughput protein purification and quality assessment for crystallization. Methods 55, 12–28
24. Aslanidis, C., and de Jong, P. J. (1990) Ligation-independent cloning of
PCR products (LIC-PCR). Nucleic Acids Res. 18, 6069 – 6074
25. Eschenfeldt, W. H., Lucy, S., Millard, C. S., Joachimiak, A., and Mark, I. D.
(2009) A family of LIC vectors for high-throughput cloning and purification of proteins. Methods Mol. Biol. 498, 105–115
26. Donnelly, M. I., Zhou, M., Millard, C. S., Clancy, S., Stols, L., Eschenfeldt,
W. H., Collart, F. R., and Joachimiak, A. (2006) An expression vector
tailored for large-scale, high-throughput purification of recombinant proteins. Protein Expr. Purif. 47, 446 – 454
27. Gill, S. C., and von Hippel, P. H. (1989) Calculation of protein extinction
coefficients from amino acid sequence data. Anal. Biochem. 182, 319 –326
28. Minor, W., Cymborowski, M., Otwinowski, Z., and Chruszcz, M. (2006)
HKL-3000: the integration of data reduction and structure solution: from
diffraction images to an initial model in minutes. Acta Crystallogr. D. Biol.
Crystallogr. 62, 859 – 866
29. French, S., and Wilson, K. (1978) Treatment of negative intensity observations. Acta Crystallogr. A. 34, 517–525
30. Padilla, J. E., and Yeates, T. O. (2003) A statistic for local intensity differences: robustness to anisotropy and pseudo-centering and utility for detecting twinning. Acta Crystallogr. D. Biol. Crystallogr. 59, 1124 –1130
31. Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans,
P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G., McCoy, A., McNicholas,
S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read,
R. J., Vagin, A., and Wilson, K. S. (2011) Overview of the CCP4 suite and
current developments. Acta Crystallogr. D. Biol. Crystallogr. 67, 235–242
32. DiMaio, F. (2013) Advances in Rosetta structure prediction for difficult
molecular-replacement problems. Acta Crystallogr. D. Biol. Crystallogr.
69, 2202–2208
33. Terwilliger, T. C., Dimaio, F., Read, R. J., Baker, D., Bunkóczi, G., Adams,
P. D., Grosse-Kunstleve, R. W., Afonine, P. V., and Echols, N. (2012)
Phenix.mr_rosetta: Molecular replacement and model rebuilding with
Phenix and Rosetta. J. Struct. Funct. Genomics 13, 81–90
34. Emsley, P., and Cowtan, K. (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126 –2132
35. Bricogne, G., Blanc, E., Brandl, M., Flensburg, C., Keller, P., Paciorek, W.,
Roversi, P., Sharff, A., Smart, O.S., Vonrhein, C. T. Womack. (2011)
BUSTER, Version 2.10.0, Global Phasing Ltd., Cambridge, UK
36. Chen, V. B., Arendall, W. B., 3rd, Headd, J. J., Keedy, D. A., Immormino,
R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., and Richardson, D. C.
(2010) MolProbity: all-atom structure validation for macromolecular
crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12–21
37. Egger, S., Chaikuad, A., Kavanagh, K. L., Oppermann, U., and Nidetzky, B.
(2011) Structure and mechanism of human UDP-glucose 6-dehydrogenase. J. Biol. Chem. 286, 23877–23887
38. Perozich, J., Leksana, A., and Hempel, J. (1995) UDP-glucose dehydrogenase: structural characteristics. Adv. Exp. Med. Biol. 372, 79 – 84
39. Singh, S., Phillips, G. N. Jr., Thorson, J. S. (2012) The structural biology of
enzymes involved in natural product glycosylation. Nat. Prod. Rep. 29,
1201–1237
40. Rao, S. T., and Rossmann, M. G. (1973) Comparison of super-secondary
structures in proteins. J. Mol. Biol. 76, 241–256

JOURNAL OF BIOLOGICAL CHEMISTRY

26257

Downloaded from http://www.jbc.org/ by guest on February 9, 2017

1. Strominger, J. L., Kalckar, H. M., Axelrod, J., and Maxwell, E. S. (1954)
Enzymatic oxidation of uridine diphosphate glucose to uridine diphosphate glucuronic acid. J. Am. Chem. Soc. 76, 6411– 6412
2. Egger, S., Chaikuad, A., Kavanagh, K. L., Oppermann, U., and Nidetzky, B.
(2010) UDP-glucose dehydrogenase: structure and function of a potential
drug target. Biochem. Soc. Trans. 38, 1378 –1385
3. Guillemette, C. (2003) Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J. 3, 136 –158
4. Raetz, C. R., Reynolds, C. M., Trent, M. S., and Bishop, R. E. (2007) Lipid A
modification systems in Gram-negative bacteria. Annu. Rev. Biochem. 76,
295–329
5. Bar-Peled, M., Griffith, C. L., and Doering, T. L. (2001) Functional cloning
and characterization of a UDP-glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis.
Proc. Natl. Acad Sci. U.S.A. 98, 12003–12008
6. Broach, B., Gu, X., and Bar-Peled, M. (2012) Biosynthesis of UDP-glucuronic acid and UDP-galacturonic acid in Bacillus cereus subsp. cytotoxis
NVH 391–98. FEBS J. 279, 100 –112
7. Alvarez, D., Merino, S., Tomás, J. M., Benedí, V. J., and Albertí, S. (2000)
Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical
isolates. Infect. Immun. 68, 953–955
8. Ahlert, J., Shepard, E., Lomovskaya, N., Zazopoulos, E., Staffa, A., Bachmann, B. O., Huang, K., Fonstein, L., Czisny, A., Whitwam, R. E., Farnet,
C. M., and Thorson, J. S. (2002) The calicheamicin gene cluster and its
iterative type I enediyne PKS. Science 297, 1173–1176
9. Bililign, T., Shepard, E. M., Ahlert, J., and Thorson, J. S. (2002) On the
origin of deoxypentoses: evidence to support a glucose progenitor in the
biosynthesis of calicheamicin. Chembiochem. 3, 1143–1146
10. Van Lanen, S. G., Oh, T. J., Liu, W., Wendt-Pienkowski, E., and Shen, B.
(2007) Characterization of the maduropeptin biosynthetic gene cluster
from Actinomadura madurae ATCC 39144 supporting a unifying paradigm for enediyne biosynthesis. J. Am. Chem. Soc. 129, 13082–13094
11. Gao, Q., Zhang, C., Blanchard, S., and Thorson, J. S. (2006) Deciphering
indolocarbazole and enediyne aminodideoxypentose biosynthesis
through comparative genomics: Insights from the AT2433 biosynthetic
locus. Chem. Biol. 13, 733–743
12. Weitnauer, G., Mühlenweg, A., Trefzer, A., Hoffmeister, D., Süssmuth,
R. D., Jung, G., Welzel, K., Vente, A., Girreser, U., and Bechthold, A. (2001)
Biosynthesis of the orthosomycin antibiotic avilamycin A: Deductions
from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and production of new antibiotics.
Chem. Biol. 8, 569 –581
13. Staffa, A., Zazopoulos, E., Mercure, S., Nowacki, P. P., and Farnet, C. M.
(July 31, 2003) Genetic locus for everninomicin biosynthesis. U. S. Patent
20,030,143,666
14. Gaisser, S., Trefzer, A., Stockert, S., Kirschning, A., and Bechthold, A.
(1997) Cloning of an avilamycin biosynthetic gene cluster from Streptomyces viridochromogenes Tü57. J. Bacteriol. 179, 6271– 6278
15. Lacour, S., Doublet, P., Obadia, B., Cozzone, A. J., and Grangeasse, C.
(2006) A novel role for protein-tyrosine kinase Etk from Escherichia coli
K-12 related to polymyxin resistance. Res. Microbiol. 157, 637– 641
16. Petranovic, D., Grangeasse, C., Macek, B., Abdillatef, M., Gueguen-Chaignon, V., Nessler, S., Deutscher, J., and Mijakovic, I. (2009) Activation of
Bacillus subtilis Ugd by the BY-kinase PtkA proceeds via phosphorylation
of its residue tyrosine 70. J. Mol. Microbiol. Biotechnol. 17, 83– 89
17. Schiller, J. G., Bowser, A. M., and Feingold, D. S. (1973) Partial purification
and properties of UDPG dehydrogenase from Escherichia coli. Biochim.
Biophys. Acta 293, 1–10
18. Turner, W., and Botha, F. C. (2002) Purification and kinetic properties of
UDP-glucose dehydrogenase from sugarcane. Arch. Biochem. Biophys.
407, 209 –216
19. Granja, A. T., Popescu, A., Marques, A. R., Sá-Correia, I., and Fialho, A. M.
(2007) Biochemical characterization and phylogenetic analysis of UDPglucose dehydrogenase from the gellan gum producer Sphingomonas elodea ATCC 31461. Appl. Microbiol. Biotechnol. 76, 1319 –1327

Structure of the TDP-␣-D-Glucose Dehydrogenase CalS8

26258 JOURNAL OF BIOLOGICAL CHEMISTRY

52.

53.

54.

55.

56.

57.

58.

59.

60.

61.

62.
63.

glucose dehydrogenase is due to a restrained hexameric structure that
favors feedback inhibition. Biochemistry 53, 8043– 8051
Kadirvelraj, R., Sennett, N. C., Polizzi, S. J., Weitzel, S., and Wood, Z. A.
(2011) Role of packing defects in the evolution of allostery and induced fit
in human UDP-glucose dehydrogenase. Biochemistry 50, 5780 –5789
Sakuraba, H., Kawai, T., Yoneda, K., and Ohshima, T. (2012) Structure of
a UDP-glucose dehydrogenase from the hyperthermophilic archaeon Pyrobaculum islandicum. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 68, 1003–1007
Rocha, J., Popescu, A. O., Borges, P., Mil-Homens, D., Moreira, L. M.,
Sá-Correia, I., Fialho, A. M., and Frazão, C. (2011) Structure of Burkholderia cepacia UDP-glucose dehydrogenase (UGD) BceC and role of Tyr10
in final hydrolysis of UGD thioester intermediate. J. Bacteriol. 193,
3978 –3987
Elshahawi, S. I., Shaaban, K. A., Kharel, M. K., and Thorson J. S. (2015) A
comprehensive review of glycosylated bacterial natural products. Chem.
Soc. Rev. 10.1039/c4cs00426d
Thibodeaux, C. J., Melançon, C. E., 3rd, and Liu, H. W. (2008) Naturalproduct sugar biosynthesis and enzymatic glycodiversification. Angew.
Chem. Int. Ed. Engl. 47, 9814 –9859
Kren, V., and Rezanka, T. (2008) Sweet antibiotics: the role of glycosidic
residues in antibiotic and antitumor activity and their randomization.
FEMS Microbiol. Rev. 32, 858 – 889
Zhang, C., Griffith, B. R., Fu, Q., Albermann, C., Fu, X., Lee, I. K., Li, L.,
Thorson, J. S. (2006) Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions. Science 313, 1291–1294
Zhang, C., Bitto, E., Goff, R. D., Singh, S., Bingman, C. A., Griffith, B. R.,
Albermann, C., Phillips, G. N. Jr., Thorson, J. S. (2008) Biochemical and
structural insights of the early glycosylation steps in calicheamicin biosynthesis. Chem. Biol. 15, 842– 853
Chang A, Singh S, Helmich KE, Goff RD, Bingman CA, Thorson JS, Phillips, G. N. Jr. (2011) Complete set of glycosyltransferase structures in the
calicheamicin biosynthetic pathway reveals the origin of regiospecificity.
Proc. Natl. Acad. Sci. 108, 17649 –17654
Simkhada, D., Oh, T. J., Pageni, B. B., Lee, H. C., Liou, K., Sohng, J. K. (2009)
Characterization of CalS9 in the biosynthesis of UDP-xylose and the production of xylosyl-attached hybrid compound. Appl. Microbiol. Biotechnol. 83, 885– 895
DeLano, W. L. (2010) The PyMOL Molecular Graphics System, version
1.7.4.4, Schrödinger, LLC, New York
Peltier-Pain, P., Singh, S., Thorson, J. S. (2015) Characterization of early
enzymes involved in TDP-aminodideoxypentose biosynthesis en route to
AT2433. Chembiochem 10.1002/cbic.201500365

VOLUME 290 • NUMBER 43 • OCTOBER 23, 2015

Downloaded from http://www.jbc.org/ by guest on February 9, 2017

41. Chen, Y. Y., Ko, T. P., Lin, C. H., Chen, W. H., and Wang, A. H. (2011)
Conformational change upon product binding to Klebsiella pneumoniae
UDP-glucose dehydrogenase: A possible inhibition mechanism for the key
enzyme in polymyxin resistance. J. Struct. Biol. 175, 300 –310
42. Egger, S., Chaikuad, A., Klimacek, M., Kavanagh, K. L., Oppermann, U.,
and Nidetzky, B. (2012) Structural and kinetic evidence that catalytic
reaction of human UDP-glucose 6-dehydrogenase involves covalent
thiohemiacetal and thioester enzyme intermediates. J. Biol. Chem. 287,
2119 –2129
43. Sommer, B. J., Barycki, J. J., and Simpson, M. A. (2004) Characterization of
human UDP-glucose dehydrogenase: Cys-276 is required for the second
of two successive oxidations. J. Biol. Chem. 279, 23590 –23596
44. Campbell, R. E., Mosimann, S. C., van De Rijn, I., Tanner, M. E., and
Strynadka, N. C. (2000) The first structure of UDP-glucose dehydrogenase
reveals the catalytic residues necessary for the two-fold oxidation. Biochemistry 39, 7012–7023
45. Hempel, J., Perozich, J., Romovacek, H., Hinich, A., Kuo, I., and Feingold,
D. S. (1994) UDP-glucose dehydrogenase from bovine liver: Primary
structure and relationship to other dehydrogenases. Protein Sci. 3,
1074 –1080
46. Easley, K. E., Sommer, B. J., Boanca, G., Barycki, J. J., and Simpson, M. A.
(2007) Characterization of human UDP-glucose dehydrogenase reveals
critical catalytic roles for lysine 220 and aspartate 280. Biochemistry 46,
369 –378
47. Fontaine, T., Lamarre, C., Simenel, C., Lambou, K., Coddeville, B., Delepierre, M., and Latgé, J. P. (2009) Characterization of glucuronic acid containing glycolipid in Aspergillus fumigatus mycelium. Carbohydr. Res. 344,
1960 –1967
48. Rocha, J., Granja, A. T., Sá-Correia, I., Fialho, A., and Frazão, C. (2010)
Cloning, expression, purification, crystallization and preliminary crystallographic studies of UgdG, an UDP-glucose dehydrogenase from Sphingomonas elodea ATCC 31461. Acta Crystallogr. Sect. F Struct. Biol. Cryst.
Commun. 66, 69 –72
49. Hung, R. J., Chien, H. S., Lin, R. Z., Lin, C. T., Vatsyayan, J., Peng, H. L.,
and Chang, H. Y. (2007) Comparative analysis of two UDP-glucose
dehydrogenases in Pseudomonas aeruginosa PAO1. J. Biol. Chem. 282,
17738 –17748
50. Rajakannan, V., Lee, H. S., Chong, S. H., Ryu, H. B., Bae, J. Y., Whang, E. Y.,
Huh, J. W., Cho, S. W., Kang, L. W., Choe, H., and Robinson, R. C. (2011)
Structural basis of cooperativity in human UDP-glucose dehydrogenase.
PLoS One 6, e25226
51. Kadirvelraj, R., Custer, G. S., Keul, N. D., Sennett, N. C., Sidlo, A. M.,
Walsh, R. M., Jr., and Wood, Z. A. (2014) Hysteresis in human UDP-

